497 related articles for article (PubMed ID: 18076132)
21. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.
Lipnik K; Greco O; Scott S; Knapp E; Mayrhofer E; Rosenfellner D; Günzburg WH; Salmons B; Hohenadl C
Virology; 2006 May; 349(1):121-33. PubMed ID: 16464484
[TBL] [Abstract][Full Text] [Related]
23. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
24. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
25. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
Hlavaty J; Portsmouth D; Stracke A; Salmons B; Günzburg WH; Renner M
Virology; 2004 Dec; 330(1):351-60. PubMed ID: 15527860
[TBL] [Abstract][Full Text] [Related]
26. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
27. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
29. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
30. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
[TBL] [Abstract][Full Text] [Related]
31. Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer.
Unsinger J; Lindenmaier W; May T; Hauser H; Wirth D
Biochem Biophys Res Commun; 2004 Jul; 319(3):879-87. PubMed ID: 15184065
[TBL] [Abstract][Full Text] [Related]
32. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
33. Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector.
Hong Y; Yu SS; Yoon NK; Kang SJ; Lee JT; Kim S; Kim JM; Lee K; Jang JW; Kim S
J Gene Med; 2008 Aug; 10(8):847-54. PubMed ID: 18563862
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of gene expression from the human c-erbB gene promoter by a retroviral vector expressing anti-gene RNA.
Okada T; Amanuma H; Okada Y; Obata M; Hayashi Y; Yamaguchi K; Yamashita J
Biochem Biophys Res Commun; 1997 Nov; 240(1):203-7. PubMed ID: 9367910
[TBL] [Abstract][Full Text] [Related]
35. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
37. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
38. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
Pan D; Aronovich E; McIvor RS; Whitley CB
Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
[TBL] [Abstract][Full Text] [Related]
39. [Transcription of antisense RNA of hepatitis B virus through retroviral mediated gene transfer].
Ji W; Wang Q; Si C; Zhang G; Liu D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):325-8. PubMed ID: 15617239
[TBL] [Abstract][Full Text] [Related]
40. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
Fragkos M; Anagnou NP; Tubb J; Emery DW
Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]